Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesOctreotide Long-Acting Repeatable in Acromegaly: Achieving Optimal Control
The Endocrinologist, 06/19/09
Cook DM - In patients with acromegaly, octreotide LAR is traditionally used as postsurgical therapy in patients with persistent disease. Although surgery remains the first-line treatment option in patients with tumors likely to be completely resected, there is a growing consensus that octreotide LAR could be used as first-line therapy in select patients. Most patients initiating treatment with somatostatin analogs begin with octreotide LAR 20 mg every 28 days. On average, 60% of patients can safely achieve normal GH and insulin-like growth factor-I levels during octreotide LAR therapy, as well as experience significant reduction in pituitary tumor volume.
Today in Adrenal Glands...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Patients
Clinical Cancer Research, 10/19/09
The pituitary-adrenal axis in adult thalassaemic patients
European Journal of Endocrinology, 11/02/09
A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials of DHEA Treatment Effects on Quality of Life in Women with Adrenal Insufficiency
Journal of Clinical Endocrinology and Metabolism, 10/09/09
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09
Medical treatment of Cushing's disease: Overview and recent findings
International Journal of General Medicine, 10/21/09
Sperm-Associated Antigen 9: A Novel Diagnostic Marker for Thyroid cancer
Journal of Clinical Endocrinology and Metabolism, 10/15/09
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Medical treatment of Cushing's disease: Overview and recent findings
International Journal of General Medicine, 10/21/09
The pituitary-adrenal axis in adult thalassaemic patients
European Journal of Endocrinology, 11/02/09
Predicting Recurrence of Nonfunctioning Pituitary Adenomas
Journal of Clinical Endocrinology and Metabolism, 10/15/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial
Diabetic Medicine, 10/01/09
Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Sponsor
Article Search
Sponsor